在严重呼吸系统衰竭中肺表面活性剂缺乏:临床评估的潜在生物标志物
Peter Schousboe1, Bülent Uslu2, Amalie Schousboe3
1Department of Pediatrics, Holbæk Hospital, 4300 Holbæk, Denmark.
Diagnostics (Basel, Switzerland)
|April 12, 2025
概括
肺表面活性剂水平,以支气管吸附剂中的二甲基酸胆 (DPPC) 测量,在患有严重呼吸衰竭的患者中显著下降. 这一发现表明DPPC是监测肺表面活性剂状态的潜在生物标志物.
科学领域:
- 肺部医学 肺部医学
- 关键的护理关键的护理
- 生物化学 生物化学
背景情况:
- 严重的呼吸衰竭会影响气膜细胞和肺表面活性剂功能.
- 目前缺乏用于肺表面活性剂的床边监测工具.
- 支气管吸附剂 (BA) 可能提供表面活性剂评估的来源.
研究的目的:
- 从重症监护室 (ICU) 的重度呼吸衰竭患者中评估BA中的肺表面活性剂水平.
- 评估测量二甲基酸胆 (DPPC) 作为表面活性生物标志物的可行性.
主要方法:
- 描述性探索性研究,涉及9名机械呼吸患者.
- 支气管吸气液在三个时间点收集:在通风的24小时内 (T1),第3天 (T2) 和第7天 (T3).
- 在BA样本的叶片体沉物中定量DPPC度.
主要成果:
- 在T1初始DPPC水平为12μM,在T2显著降低至8μM (p=0.0039).
- 通过T3.3观察到DPPC水平进一步下降到2-5μM.
- 在BA中的DPPC水平可以在患有呼吸衰竭的重症患者中测量.
结论:
- 在支气管吸附液中测量DPPC水平可以作为肺表面活性剂状态的生物标志物.
- 这表明在临床实践中对肺表面活性剂的临床评估有潜力.
- 可靠的表面活性生物标志物可以帮助临床决定外源表面活性剂治疗.
更多相关视频
07:20Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS
Published on: September 7, 2016
11.1K
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
49.4K
相关概念视频
Breathing
56.6K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
56.6K
Acute Respiratory Failure-V
110
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
110
Acute Respiratory Failure-III
146
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
146
Acute Respiratory Failure-IV
108
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
108
Acute Respiratory Failure-II
144
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
144
Respiratory Assessment: Purpose and Indications
979
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
979
